Azoreductase-Responsive Self-Assembled 10-Hydroxycamptothecin Nanofibers for Tumor-Specific Imaging and Therapy
Biomacromolecules · 09.11.2026 · 27 (11) · 7261-7273
DOI: 10.1021/acs.biomac.6c01286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 02.10.2026. Verfasst von Li-Song Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tia…. Hauptthemen laut MEDLINE: Camptothecin, Prodrugs, Nanofibers, NADH, NADPH Oxidoreductases. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Tianjin Municipal Science and Technology Program.
Abstract (Originalsprache)
Hypoxia is a defining feature of the tumor microenvironment (TME). The overexpression of azoreductase (AzoR) in hypoxic conditions enables it to serve as a trigger for drug release in tumor therapy. Developing a theranostic agent that is selectively activated in TME is vital for enhancing anti-tumor efficacy while minimizing side effects. Here, we designed and synthesized a supramolecular self-assembled nanofiber prodrug, NFK-(Azo)-HCPT, by conjugating a self-assembling peptide with the chemotherapeutic agent 10-hydroxycamptothecin (HCPT) via hypoxia-responsive azobenzene linkers. The prodrug exhibits excellent water solubility and forms supramolecular nanofibers through alkaline phosphatase (ALP)-catalyzed dephosphorylation. NFK-(Azo)-HCPT achieves significantly higher cellular uptake and tumor cell inhibition than HCPT alone. Its tumor targeting via the enhanced permeability and retention effects, showing selective activation and accumulation in tumors. NFK-(Azo)-HCPT reduced tumor size without altering bodyweight, validating its therapeutic potential. Collectively, the hypoxia-sensitive, enzyme-catalyzed self-assembly prodrug strategy offers a promising approach for precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin300350, China.
- State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, Tianjin300350, China.
- Department of Pharmacy, Xuanwu Hospital Capital Medical University, Beijing100053, China.
ORCID-Profile: Li-Song Zhang, Zhi-Song Zhang
Förderung
- National Natural Science Foundation of China (NSFC)
- Tianjin Municipal Science and Technology Program
Zitieren
APA
Zhang, L. S., Wang, T. H., Wang, Y. Y., Cui, H. Y., Weng, S. T., Liu, C., Zhao, W. W., Zhu, Y. P., Li, L. Y., & Zhang, Z. S. (2026). Azoreductase-Responsive Self-Assembled 10-Hydroxycamptothecin Nanofibers for Tumor-Specific Imaging and Therapy. Biomacromolecules, 27(11), 7261-7273. https://doi.org/10.1021/acs.biomac.6c01286
Vancouver
Zhang LS, Wang TH, Wang YY, Cui HY, Weng ST, Liu C, et al. Azoreductase-Responsive Self-Assembled 10-Hydroxycamptothecin Nanofibers for Tumor-Specific Imaging and Therapy. Biomacromolecules. 2026;27(11):7261-7273. doi:10.1021/acs.biomac.6c01286
BibTeX
@article{Zhang2026,
author = {Zhang, Li-Song and Wang, Tian-Hang and Wang, Yu-Ying and Cui, Hai-Yan and Weng, Shi-Ting and Liu, Chun and Zhao, Wen-Wen and Zhu, Yi-Pan and Li, Lu-Yuan and Zhang, Zhi-Song},
title = {Azoreductase-Responsive Self-Assembled 10-Hydroxycamptothecin Nanofibers for Tumor-Specific Imaging and Therapy},
journal = {Biomacromolecules},
year = {2026},
volume = {27},
number = {11},
pages = {7261--7273},
doi = {10.1021/acs.biomac.6c01286}
}
EUVIMED